Savara (SVRA) Stock Forecast & Price Target

Compare

1,228 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

SVRA Analyst Ratings

Strong Buy

5 Buy

0 Hold

0 Sell

Based on 5 analysts giving stock ratings to

Savara

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

SVRA Stock 12 Month Forecast

Average Price Target

$9.20

▲(32.56% Upside)

Based on 5 Wall Street analysts offering 12 month price targets for Savara in the last 3 months. The average price target is $9.20 with a high forecast of $11.00 and a low forecast of $7.00. The average price target represents a 32.56% change from the last price of $6.94.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","12":"$12","3.75":"$3.75","6.5":"$6.5","9.25":"$9.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":11,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$11.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9.2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$9.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$7.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,3.75,6.5,9.25,12],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"May<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.84,6.236923076923077,6.633846153846154,7.030769230769231,7.427692307692308,7.8246153846153845,8.221538461538461,8.618461538461538,9.015384615384615,9.412307692307692,9.80923076923077,10.206153846153846,10.603076923076923,{"y":11,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.84,6.098461538461538,6.356923076923077,6.615384615384615,6.873846153846154,7.132307692307692,7.39076923076923,7.649230769230769,7.907692307692307,8.166153846153845,8.424615384615384,8.683076923076921,8.94153846153846,{"y":9.2,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.84,5.929230769230769,6.018461538461539,6.107692307692307,6.196923076923077,6.286153846153846,6.375384615384616,6.464615384615384,6.553846153846154,6.643076923076923,6.7323076923076925,6.821538461538461,6.9107692307692306,{"y":7,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.99,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.6,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.3,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.07,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.49,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.86,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.26,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.4,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.59,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.31,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.54,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.15,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.84,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$11.00

Average Price Target$9.20

Lowest Price Target$7.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Francois Brisebois

LifeSci Capital

$11

Buy

58.50%

Upside

Reiterated

12/10/25

Savara's MOLBREEVI: A Promising Solution for aPAP with Blockbuster Potential

Andrew Fein

H.C. Wainwright

Buy

15.27%

Upside

Reiterated

11/14/25

Savara's Strategic Positioning and Market Readiness for Molbreevi's Potential LaunchValuation and Risks. Our price target of $8 is based on an equally weighted composite of: (a) $9.14 per share, as a 25x multiple of taxed and diluted $1.01 discounted back to and (b) an NPV of $7.72 per share, discounted cash flow analysis using a 12% discount rate and 2% growth rate, in line with the expected discount and growth parameters of a development-stage biotechnology company.

Andreas Argyrides

Oppenheimer

$8→$9

Buy

29.68%

Upside

Reiterated

11/14/25

Oppenheimer Reaffirms Their Buy Rating on Savara (SVRA)

Jonathan Wolleben

Citizens JMP

$8→$11

Buy

58.50%

Upside

Reiterated

10/23/25

Savara price target raised to $11 from $8 at Citizens JMPSavara price target raised to $11 from $8 at Citizens JMP

Benjamin Burnett

Wells Fargo

Buy

0.86%

Upside

Reiterated

10/17/25

We are maintaining the current ratings, price targets, and estimates.

Vamil Divan

Guggenheim

$8→$11

Buy

58.50%

Upside

Reiterated

09/08/25

Guggenheim Sticks to Its Buy Rating for Savara (SVRA)Multiple Positive Updates Drive Our Price Target to $11 (From $8); Reiterate Buy Rating

Yasmeen Rahimi

Piper Sandler

$16

Buy

130.55%

Upside

Reiterated

09/03/25

Piper Sandler Sticks to Their Buy Rating for Savara (SVRA)

Liisa Bayko

Evercore ISI

Hold

-71.18%

Downside

Reiterated

08/04/25

Evercore ISI Reaffirms Their Hold Rating on Savara (SVRA)

Andrew Tsai

Jefferies

$8.5

Buy

22.48%

Upside

Reiterated

03/26/25

Savara's Strategic Positioning and Market Potential for Molbreevi in aPAP Treatment

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Francois Brisebois

LifeSci Capital

$11

Buy

58.50%

Upside

Reiterated

12/10/25

Savara's MOLBREEVI: A Promising Solution for aPAP with Blockbuster Potential

Andrew Fein

H.C. Wainwright

Buy

15.27%

Upside

Reiterated

11/14/25

Andreas Argyrides

Oppenheimer

$8→$9

Buy

29.68%

Upside

Reiterated

11/14/25

Oppenheimer Reaffirms Their Buy Rating on Savara (SVRA)

Jonathan Wolleben

Citizens JMP

$8→$11

Buy

58.50%

Upside

Reiterated

10/23/25

Savara price target raised to $11 from $8 at Citizens JMPSavara price target raised to $11 from $8 at Citizens JMP

Benjamin Burnett

Wells Fargo

Buy

0.86%

Upside

Reiterated

10/17/25

We are maintaining the current ratings, price targets, and estimates.

Vamil Divan

Guggenheim

$8→$11

Buy

58.50%

Upside

Reiterated

09/08/25

Guggenheim Sticks to Its Buy Rating for Savara (SVRA)Multiple Positive Updates Drive Our Price Target to $11 (From $8); Reiterate Buy Rating

Yasmeen Rahimi

Piper Sandler

$16

Buy

130.55%

Upside

Reiterated

09/03/25

Piper Sandler Sticks to Their Buy Rating for Savara (SVRA)

Liisa Bayko

Evercore ISI

Hold

-71.18%

Downside

Reiterated

08/04/25

Evercore ISI Reaffirms Their Hold Rating on Savara (SVRA)

Andrew Tsai

Jefferies

$8.5

Buy

22.48%

Upside

Reiterated

03/26/25

Savara's Strategic Positioning and Market Potential for Molbreevi in aPAP Treatment

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Savara

1 Month

xxx

Success Rate

6/10 ratings generated profit

Average Return

+13.41%

reiterated a xxx

rating 3 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of +13.41% per trade.

3 Months

xxx

Success Rate

6/10 ratings generated profit

Average Return

+17.87%

reiterated a xxx

rating 3 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +17.87% per trade.

1 Year

Yasmeen RahimiPiper Sandler

Success Rate

7/12 ratings generated profit

Average Return

+26.78%

reiterated a buy rating 3 months ago

Copying Yasmeen Rahimi's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of +26.78% per trade.

2 Years

xxx

Success Rate

15/15 ratings generated profit

Average Return

+81.64%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +81.64% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SVRA Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, SVRA has received 8 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SVRA average Analyst price target in the past 3 months is 9.20.

Each month's total comprises the sum of three months' worth of ratings.

SVRA Financial Forecast

SVRA Earnings Forecast

Next quarter’s earnings estimate for SVRA is -$0.12 with a range of -$0.13 to -$0.10. The previous quarter’s EPS was -$0.14. SVRA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year SVRA has Performed in-line its overall industry.

SVRA Sales Forecast

Next quarter’s sales forecast for SVRA is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. SVRA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year SVRA has Performed in-line its overall industry.

SVRA Stock Forecast FAQ

What is SVRA’s average 12-month price target, according to analysts?

Based on analyst ratings, Savara’s 12-month average price target is 9.20.

What is SVRA’s upside potential, based on the analysts’ average price target?

Savara has 32.56% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is SVRA a Buy, Sell or Hold?

Savara has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.

What is Savara’s price target?

The average price target for Savara is 9.20. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $11.00 ,the lowest forecast is $7.00. The average price target represents 32.56% Increase from the current price of $6.94.

What do analysts say about Savara?

Savara’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.

How can I buy shares of SVRA?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Savara (SVRA) Stock Forecast & Price Target

SVRA Analyst Ratings

SVRA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Savara

SVRA Analyst Recommendation Trends

SVRA Financial Forecast

SVRA Earnings Forecast

SVRA Sales Forecast

SVRA Stock Forecast FAQ

Detailed List of Analyst Forecasts